Observational studyMedicine2025
Clinical impact of whole-process high-quality nursing services in an infectious disease ward: A retrospective cohort study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates whether whole-process high-quality nursing services (WP-HQNS) improve safety, efficiency, and patient experience in an infectious disease ward. A retrospective cohort of 1394 inpatients (WP-HQNS, n = 740; routine care, n = 654) admitted between June 2023 and February 2025 was analyzed. The primary outcome was hospital-acquired infection (HAI); the key secondary outcome was any nurse-sensitive adverse event (NSAE). Other endpoints included adverse-event profiles, length of stay, time to defervescence, readmission, mortality, and patient-experience indicators. Groups were comparable at baseline. WP-HQNS was associated with fewer HAIs (8.78% vs 13.15%; P = .009; risk ratio ≈ 0.67) and lower NSAE rates (10.95% vs 18.04%; P < .001). Hospitalization (-1.5 days) and time to defervescence (-0.7 days) were shorter (both P < .001). Readmission and mortality were numerically reduced. Patient satisfaction, discharge education, and 7-day follow-up completion were all higher under WP-HQNS (all P < .001). WP-HQNS reduced nosocomial risk and nursing-sensitive harm, improved recovery efficiency, and enhanced patient engagement. These findings support broader implementation and warrant prospective multicenter validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.